Insider · CIK 0001604800
Jeffrey T L Smith
Files at ZYME (Zymeworks Inc.). First filing Jan 5, 2026, latest Jan 12, 2026.
Jeffrey T L Smith files SEC Form 4 as officer at ZYME (Zymeworks Inc.). Since Jan 5, 2026, Jeffrey T L Smith has reported 0 open-market buys worth $0 and 2 open-market sells worth $476k, the latest filed on Jan 12, 2026.
A track record needs three past buys with six months of prices behind them; Jeffrey T L Smith has 0, so none is measured yet.
The newest scored trade: sold $211k of ZYME on Jan 12, 2026, filed Jan 12, 2026, scored 37 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $476k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZYME: Zymeworks Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Zymeworks Inc. | $211k 9,310 shares | -26% | +145% from low-16% from high | |
| 38Weak | Zymeworks Inc. | $264k 10,538 shares | -36% | +170% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 6, 2026 | ZYME Zymeworks Inc. | 247,333 0.34% of outstanding | $6.1M | Mar 6, 2026 | $476k |
| Jan 12, 2026 | ZYME Zymeworks Inc. | 9,310 0.01% of outstanding | $216k | Jan 12, 2026 | $264k |
| Jan 5, 2026 | ZYME Zymeworks Inc. | 10,538 0.01% of outstanding | $281k | Jan 5, 2026 | none |
| Jan 6, 2025 | ZYME Zymeworks Inc. | 11,110 0.02% of outstanding | $161k | Jan 6, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | MOption exercise Common Stock | +17,666 | $0.00 | $0 | 36,018 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | SOpen-market sale Common Stock | -9,310 | $22.67 | $211k | 26,708 | Jan 12, 2026 |
| Jan 12, 2026 | ZYME Zymeworks Inc. | MOption exercise Restricted Stock Unitderivative | -17,666 | $0.00 | $0 | 35,334 | Jan 12, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | MOption exercise Common Stock | +20,000 | $0.00 | $0 | 28,890 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | SOpen-market sale Common Stock | -10,538 | $25.10 | $264k | 18,352 | Jan 5, 2026 |
| Jan 5, 2026 | ZYME Zymeworks Inc. | MOption exercise Restricted Stock Unitderivative | -20,000 | $0.00 | $0 | 20,000 | Jan 5, 2026 |
Questions about Jeffrey T L Smith
Answered from the filings on this page, as of the latest one.
Is Jeffrey T L Smith buying or selling?
In the last 12 months Jeffrey T L Smith reported 0 open-market buys worth $0 and 2 open-market sells worth $476k on SEC Form 4; the latest was sold $211k of ZYME on Jan 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Jeffrey T L Smith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey T L Smith has 0.
Where does Jeffrey T L Smith file Form 4?
Jeffrey T L Smith has filed Form 4 at ZYME (Zymeworks Inc.) as EVP & Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.